United Kingdom· GB-APID-8014111000001103
Vaniqa 11.5% cream
A eflornithine product containing eflornithine, registered in United Kingdom by Almirall Ltd. The same ATC class is registered in 12 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Eflornithine is registered in 12 of 19 countries.
Countries holding a registration under ATC D11AX16 (eflornithine), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 7 of them publish a price we can compare per daily dose
Eflornithine · ATC D11AX16
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Eflornithine
- Manufacturer
- Almirall Ltd
- Country
- United Kingdom (GB)
- ATC code
- D11AX16
- ATC class
- Eflornithine
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin4042762054392
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Eflornithine in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainVANIQA 11,5 % CREMAAlmirall S.A.
- SwitzerlandIfinwil 192 mg, TablettenNorgine AG
- CzechiaVANIQAAlmirall, S.A., Barcelona
- IrelandVaniqa 11.5%Almirall, S.A.
- NorwayIwilfinUS WorldMeds
- PolandVaniqaAlmirall, S.A.
- SwedenVaniqa 11,5 % KrämAlmirall S.A.
- BelgiumVaniqa 11.5 %Almirall
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- France · Ornidyl
- Iceland · Vaniqa
- Liechtenstein · Vaniqa
- Norway · Vaniqa
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/dd69caad-82b7-41c6-be3a-1fbae4e8f88e GET /v1/drugs/dd69caad-82b7-41c6-be3a-1fbae4e8f88e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "8014111000001103",
"desc": "Vaniqa 11.5% cream (Almirall Ltd)",
"form": "Cutaneous cream",
"vpid": "39691811000001104",
"source": "dmd",
"vtm_id": "775738006",
"strength": "115 mg",
"substance": "Eflornithine",
"ingredient": "Eflornithine hydrochloride monohydrate",
"supplier_code": "13610411000001109"
}See everything about eflornithine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.